Improve diagnosis for Canadians. With Roche. In Montréal.
Roche Diagnostics Canada is a long-standing partner of Greater Montréal’s healthcare system, putting its expertise to work in support of hospitals, laboratories and research centres. By enhancing both the speed and accuracy of diagnosis, the company delivers critical information to guide patient treatment and care.
At a glance
- Global headquarters: Basel, Switzerland
- Sector: Life sciences and health technologies
- Established in Greater Montréal since 1931
- Close collaboration with Greater Montréal’s university health centres
- Strong commitment to R&D
Pushing the boundaries of precision medicine
Located in the heart of Laval’s Cité de la Biotech, Roche Diagnostics Canada plays a key role in Greater Montréal’s life sciences ecosystem. This unique environment, where life sciences and artificial intelligence converge, provides the ideal conditions to develop next-generation medical solutions.
Every day, Roche supports hospitals and laboratories across Canada with advanced diagnostic instruments, testing solutions, and digital health technologies. The goal is clear: equip healthcare professionals with the tools they need to deliver fast, accurate diagnoses, ultimately improving patient outcomes nationwide.
Innovation driven by CHUM’s excellence
Roche Diagnostics Canada partnered with the Centre hospitalier de l’Université de Montréal (CHUM) in 2025 to evaluate Canada’s first fully automated mass spectrometry platform.
By combining Roche’s innovation capabilities with the clinical expertise at CHUM (one of the largest francophone academic medical centres in North America), this collaboration enables the validation of cutting-edge technologies in real-world clinical and analytical settings.
A driver for Roche and for the local economy
Roche Diagnostics’ presence in Greater Montréal generates strategic and lasting benefits:
- Invests 19% of its revenue in R&D, supporting technologies that contribute to the diagnosis of nearly one in four Canadians (Roche Annual Financial Report 2025)
- Trains laboratory professionals on advanced technology platforms at its local facilities
- Deploys leading-edge solutions powered by AI, including automated mass spectrometry, next-generation sequencing, and continuous glucose monitoring
- Strengthens Greater Montréal’s global positioning as a hub for life sciences and health technologies
Join a leading life sciences and AI hub
Greater Montréal ranks among North America’s leading hubs in life sciences and health technologies, driven by major investments in biopharmaceutical innovation and AI applied to healthcare.
The region offers a unique environment to build strategic partnerships and accelerate innovation.
Learn more about Greater Montréal’s advantages and investment opportunities.
Newsletter
Don't miss out
Sign up to receive the latest news from Montréal International.